Verve Therapeutics Files 8-K on Shareholder Vote Matters
| Field | Detail |
|---|---|
| Company | Verve Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 10, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
TL;DR
Verve Therapeutics filed an 8-K for shareholder vote matters on 6/5.
AI Summary
Verve Therapeutics, Inc. filed an 8-K on June 10, 2025, reporting on matters submitted to a vote of security holders as of June 5, 2025. The filing details the company's principal executive offices located at 201 Brookline Avenue, Suite 601, Boston, MA 02215, and its telephone number is (617) 603-0070.
Why It Matters
This filing indicates a formal process of shareholder engagement and voting on corporate matters, which is a standard but important procedural step for publicly traded companies.
Risk Assessment
Risk Level: low — The filing is a routine procedural disclosure regarding shareholder votes and does not contain new financial or operational risks.
Key Players & Entities
- Verve Therapeutics, Inc. (company) — Registrant
- June 5, 2025 (date) — Date of earliest event reported
- June 10, 2025 (date) — Date of Report
- 201 Brookline Avenue, Suite 601, Boston, MA 02215 (location) — Principal Executive Offices
- (617) 603-0070 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on matters submitted to a vote of security holders, with the earliest event reported on June 5, 2025.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on June 10, 2025.
What is Verve Therapeutics, Inc.'s principal executive office address?
Verve Therapeutics, Inc.'s principal executive offices are located at 201 Brookline Avenue, Suite 601, Boston, Massachusetts 02215.
What is the telephone number for Verve Therapeutics, Inc.?
The telephone number for Verve Therapeutics, Inc., including area code, is (617) 603-0070.
What is the state of incorporation for Verve Therapeutics, Inc.?
Verve Therapeutics, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding Verve Therapeutics, Inc..